Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Recs

0
Player Avatar slih (< 20) Submitted: 1/26/2012 12:58:31 AM : Outperform Start Price: $38.95 LLY Score: +6.33

veternary products; retained corporate brainpower

Featured Broker Partners


Advertisement